COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Cosmos Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.33−0.01 (-1.90%)
Close on Oct 19, 2026
- Market cap
- $19.48M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.7100 (−68.60%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Cosmos Health Inc. grew revenue 33.8% to $73.73M over the twelve months to Jun 30, 2026. Free cash flow was -$9.93M.
Revenue
$73.73M
+33.8% vs. a year earlier
Operating income
-$18.33M
TTM Q2 2026
Free cash flow
-$9.93M
TTM Q2 2026
EPS, diluted
-$0.61
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $19.48M
- P/E ratio
- –
- Price to sales
- 0.26
- Price to book
- 0.94
- Dividend yield
- –
- Free cash flow yield
- -51.00%
Fundamentals
- Revenue
- $73.73M
- Net income
- -$24.39M
- EPS, diluted
- -$0.61
- Free cash flow
- -$9.93M
- Book value per share
- $0.35
- Diluted shares
- 60M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$73.73M+33.8% YoY
Gross profit
$7.57M+39.7% YoY
Operating income
-$18.33M
Net income
-$24.39M
EPS, diluted
-$0.61
Free cash flow
-$9.93M
Reported periodTrailing twelve months